Patient population
Of all patients in the overall FAS study population (Baseline characteristics were generally similar between the two treatment groups for patients in this MEC group; however, there were more females in the aprepitant group, but more patients receiving carboplatin in the NEPA group (Table Patient baseline characteristics (overall MEC group).